• 954-428-2480
  • 954-428-2904
  • Mon to Fri 8:30am to 5:00pm

RESEARCH

CLOSTRIDIUM DIFFICILE INFECTION (CDI)

A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole with vancomycin in the treatment of Clostridium difficile infection (CDI).

You may qualify if:

  • Have been diagnosed with infection for Clostridium difficile within the past 24 hours and have not started antibiotic treatment.